APO RESEARCH · REPORT
Telepsychiatry
Telepsychiatry is a branch of telemedicine defined by the electronic delivery of psychiatric services to patients. This typically includes providing psychiatric assessments, therapeutic services, and medication management via telecommunication technology, most commonly videoconferencing.
Product & engineering
Understand the product.
Telepsychiatry is a branch of telemedicine defined by the electronic delivery of psychiatric services to patients. This typically includes providing psychiatric assessments, therapeutic services, and medication management via telecommunication technology, most commonly videoconferencing.
Selected research
Market Outlook & Growth Opportunities
Global Telepsychiatry Market Outlook and Growth Opportunities 2026
Market perspective
Telepsychiatry is a branch of telemedicine defined by the electronic delivery of psychiatric services to patients. This typically includes providing psychiatric assessments, therapeutic services, and medication management via telecommunication technology, most commonly videoconferencing.
Global Telepsychiatry key players include InSight Telepsychiatry, American Telepsychiatrists, Iris Telehealth, JSA Health, Advanced Telemed Services, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share over 80%, followed by Asia and Europe, both have a share over 10%.
Read the full market overview
In terms of application, the largest application is Adult, followed by Teenagers, Geriatric Populations, etc.
This report provides an overview of the global Telepsychiatry market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Telepsychiatry and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Telepsychiatry revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Telepsychiatry market.
Telepsychiatry Segment by Company
InSight Telepsychiatry
American Telepsychiatrists
Iris Telehealth
JSA Health
Advanced Telemed Services
FasPsych
Genoa
Encounter Telehealth
Arcadian Telepsychiatry
InnovaTel
Telepsychiatry Segment by Type
Routine Telepsychiatry
Forensic Telepsychiatry
Crisis Telepsychiatry
In-Home Telepsychiatry
Telepsychiatry Segment by End User
Adults
Teenagers
Geriatric Populations
Telepsychiatry Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Telepsychiatry status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Telepsychiatry key companies, revenue, market share, and recent developments.
3. To split the Telepsychiatry breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Telepsychiatry market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Telepsychiatry significant trends, drivers, influence factors in global and regions.
6. To analyze Telepsychiatry competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Telepsychiatry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Telepsychiatry and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Telepsychiatry.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Telepsychiatry industry.
Chapter 3: Detailed analysis of Telepsychiatry company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Telepsychiatry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Telepsychiatry in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Routine Telepsychiatry
- Forensic Telepsychiatry
- Crisis Telepsychiatry
- In-Home Telepsychiatry
Applications
- Adults
- Teenagers
- Geriatric Populations
Companies covered
- InSight Telepsychiatry
- American Telepsychiatrists
- Iris Telehealth
- JSA Health
- Advanced Telemed Services
- FasPsych
- Genoa
- Encounter Telehealth
- Arcadian Telepsychiatry
- InnovaTel
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Telepsychiatry Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Telepsychiatry Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Telepsychiatry Market Dynamics
- 2.1 Telepsychiatry Industry Trends
- 2.2 Telepsychiatry Industry Drivers
- 2.3 Telepsychiatry Industry Opportunities and Challenges
- 2.4 Telepsychiatry Industry Restraints
3 Telepsychiatry Market by Company
- 3.1 Global Telepsychiatry Company Revenue Ranking in 2025
- 3.2 Global Telepsychiatry Revenue by Company (2021-2026)
- 3.3 Global Telepsychiatry Company Ranking (2024-2026)
- 3.4 Global Telepsychiatry Company Manufacturing Base and Headquarters
- 3.5 Global Telepsychiatry Company Product Type and Application
- 3.6 Global Telepsychiatry Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Telepsychiatry Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Telepsychiatry Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Telepsychiatry Market by Type
- 4.1 Telepsychiatry Type Introduction
- 4.1.1 Routine Telepsychiatry
- 4.1.2 Forensic Telepsychiatry
- 4.1.3 Crisis Telepsychiatry
- 4.1.4 In-Home Telepsychiatry
- 4.2 Global Telepsychiatry Sales Value by Type
- 4.2.1 Global Telepsychiatry Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Telepsychiatry Sales Value by Type (2021-2032)
- 4.2.3 Global Telepsychiatry Sales Value Share by Type (2021-2032)
5 Telepsychiatry Market by Application
- 5.1 Telepsychiatry Application Introduction
- 5.1.1 Adults
- 5.1.2 Teenagers
- 5.1.3 Geriatric Populations
- 5.2 Global Telepsychiatry Sales Value by Application
- 5.2.1 Global Telepsychiatry Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Telepsychiatry Sales Value by Application (2021-2032)
- 5.2.3 Global Telepsychiatry Sales Value Share by Application (2021-2032)
6 Telepsychiatry Regional Value Analysis
- 6.1 Global Telepsychiatry Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Telepsychiatry Sales Value by Region (2021-2032)
- 6.2.1 Global Telepsychiatry Sales Value by Region: 2021-2026
- 6.2.2 Global Telepsychiatry Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Telepsychiatry Sales Value (2021-2032)
- 6.3.2 North America Telepsychiatry Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Telepsychiatry Sales Value (2021-2032)
- 6.4.2 Europe Telepsychiatry Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Telepsychiatry Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Telepsychiatry Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Telepsychiatry Sales Value (2021-2032)
- 6.6.2 South America Telepsychiatry Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Telepsychiatry Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Telepsychiatry Sales Value Share by Country, 2025 VS 2032
7 Telepsychiatry Country-level Value Analysis
- 7.1 Global Telepsychiatry Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Telepsychiatry Sales Value by Country (2021-2032)
- 7.2.1 Global Telepsychiatry Sales Value by Country (2021-2026)
- 7.2.2 Global Telepsychiatry Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.7.2 France Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.14.2 China Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.17.2 India Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Telepsychiatry Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Telepsychiatry Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Telepsychiatry Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Telepsychiatry Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 InSight Telepsychiatry
- 8.1.1 InSight Telepsychiatry Company Information
- 8.1.2 InSight Telepsychiatry Business Overview
- 8.1.3 InSight Telepsychiatry Telepsychiatry Revenue and Gross Margin (2021-2026)
- 8.1.4 InSight Telepsychiatry Telepsychiatry Product Portfolio
- 8.1.5 InSight Telepsychiatry Recent Developments
- 8.2 American Telepsychiatrists
- 8.2.1 American Telepsychiatrists Company Information
- 8.2.2 American Telepsychiatrists Business Overview
- 8.2.3 American Telepsychiatrists Telepsychiatry Revenue and Gross Margin (2021-2026)
- 8.2.4 American Telepsychiatrists Telepsychiatry Product Portfolio
- 8.2.5 American Telepsychiatrists Recent Developments
- 8.3 Iris Telehealth
- 8.3.1 Iris Telehealth Company Information
- 8.3.2 Iris Telehealth Business Overview
- 8.3.3 Iris Telehealth Telepsychiatry Revenue and Gross Margin (2021-2026)
- 8.3.4 Iris Telehealth Telepsychiatry Product Portfolio
- 8.3.5 Iris Telehealth Recent Developments
- 8.4 JSA Health
- 8.4.1 JSA Health Company Information
- 8.4.2 JSA Health Business Overview
- 8.4.3 JSA Health Telepsychiatry Revenue and Gross Margin (2021-2026)
- 8.4.4 JSA Health Telepsychiatry Product Portfolio
- 8.4.5 JSA Health Recent Developments
- 8.5 Advanced Telemed Services
- 8.5.1 Advanced Telemed Services Company Information
- 8.5.2 Advanced Telemed Services Business Overview
- 8.5.3 Advanced Telemed Services Telepsychiatry Revenue and Gross Margin (2021-2026)
- 8.5.4 Advanced Telemed Services Telepsychiatry Product Portfolio
- 8.5.5 Advanced Telemed Services Recent Developments
- 8.6 FasPsych
- 8.6.1 FasPsych Company Information
- 8.6.2 FasPsych Business Overview
- 8.6.3 FasPsych Telepsychiatry Revenue and Gross Margin (2021-2026)
- 8.6.4 FasPsych Telepsychiatry Product Portfolio
- 8.6.5 FasPsych Recent Developments
- 8.7 Genoa
- 8.7.1 Genoa Company Information
- 8.7.2 Genoa Business Overview
- 8.7.3 Genoa Telepsychiatry Revenue and Gross Margin (2021-2026)
- 8.7.4 Genoa Telepsychiatry Product Portfolio
- 8.7.5 Genoa Recent Developments
- 8.8 Encounter Telehealth
- 8.8.1 Encounter Telehealth Company Information
- 8.8.2 Encounter Telehealth Business Overview
- 8.8.3 Encounter Telehealth Telepsychiatry Revenue and Gross Margin (2021-2026)
- 8.8.4 Encounter Telehealth Telepsychiatry Product Portfolio
- 8.8.5 Encounter Telehealth Recent Developments
- 8.9 Arcadian Telepsychiatry
- 8.9.1 Arcadian Telepsychiatry Company Information
- 8.9.2 Arcadian Telepsychiatry Business Overview
- 8.9.3 Arcadian Telepsychiatry Telepsychiatry Revenue and Gross Margin (2021-2026)
- 8.9.4 Arcadian Telepsychiatry Telepsychiatry Product Portfolio
- 8.9.5 Arcadian Telepsychiatry Recent Developments
- 8.10 InnovaTel
- 8.10.1 InnovaTel Company Information
- 8.10.2 InnovaTel Business Overview
- 8.10.3 InnovaTel Telepsychiatry Revenue and Gross Margin (2021-2026)
- 8.10.4 InnovaTel Telepsychiatry Product Portfolio
- 8.10.5 InnovaTel Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst